title: Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator.
abstract: •Malignant peritoneal mesothelioma is a rare aggressive tumor with approximately 400 new cases annually in the US.•In optimal cytoreduction HIPEC is the standard treatment.•In suboptimal cytoreduction IV cisplatin and pemetrexed have high efficacy.
authors.affiliation: Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA.
authors.forename: Kassondra S
authors.initials: KS
authors.lastname: Grzankowski
authors.affiliation: Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA.
authors.forename: Rachel M
authors.initials: RM
authors.lastname: Brightwell
authors.affiliation: Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY, USA.
authors.forename: John M
authors.initials: JM
authors.lastname: Kasznica
authors.affiliation: Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA.
authors.forename: Kunle O
authors.initials: KO
authors.lastname: Odusi
keywords: HIPEC; Pemetrexed; Peritoneal mesothelioma